Risk Assessment and Prediction of Severe or Critical COVID-19 Illness in Older Adults

References

• Epidemiology Working Group for NCIP Epidemic Response CCfDC, Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chinese J Epidemiol. 2020;41(02):145–151.
   Google Scholar
• Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. New England J Med. 2020;382(13):1199–1207. doi:10.1056/NEJMoa200131631995857
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-531986264
   PubMed Web of Science ®Google Scholar
• Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-332171076
   PubMed Web of Science ®Google Scholar
• Guan WJ, Ni ZY, Hu Y, Liang WH, Zhong NS. Clinical characteristics of coronavirus disease 2019 in China. New England J Med. 2020;382:18. doi:10.1056/NEJMoa2002032
   Web of Science ®Google Scholar
• Commission. CNH. Diagnosis and treatment protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin Med J. 2020;133(9):1087–1095. doi:10.1097/CM9.000000000000081932358325
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, Qu J, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:10223. doi:10.1016/S0140-6736(20)30211-7
   Web of Science ®Google Scholar
• Xu X, Chen P, Wang J, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457–460. doi:10.1007/s11427-020-1637-532009228
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020;525(1):135–140. doi:10.1016/j.bbrc.2020.02.071
   PubMed Web of Science ®Google Scholar
• Ren -L-L, Wang Y-M, Wu Z-Q, et al. Identification of a novel coronavirus causing severe pneumonia in human. Chin Med J. 2020;133(9):1015–1024. doi:10.1097/CM9.000000000000072232004165
   PubMed Web of Science ®Google Scholar
• Li R, Qiao S, Zhang G. Analysis of angiotensin-converting enzyme 2 (ACE2) from different species sheds some light on cross-species receptor usage of a novel coronavirus 2019-nCoV. J Infection. 2020;80(4):469–496.
   Web of Science ®Google Scholar
• Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020;40(9):2095–2103. doi:10.1111/liv.1445532239796
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-732015507
   PubMed Web of Science ®Google Scholar
• Liu J, Zheng X, Tong Q, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV. J Med Virol. 2020;92(5):491–494. doi:10.1002/jmv.2570932056249
   PubMed Web of Science ®Google Scholar
• Guo L, Wei D, Zhang X, Wu Y, Li Q. Clinical features predicting mortality risk in patients with viral pneumonia: the mulbsta score. Front Microbiol. 2019;10:2752. doi:10.3389/fmicb.2019.0275231849894
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang Y, Zhang C, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Nature Public Health Emergency Collection. 2020;63:3.
   Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061. doi:10.1001/jama.2020.158532031570
   PubMed Web of Science ®Google Scholar
• Palmieri L, Vanacore N, Donfrancesco C, et al. Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy. J Gerontol. 2020;75(9):1796–1800. doi:10.1093/gerona/glaa146
   Google Scholar
• Bello-Chavolla OY, González-Díaz A, Antonio-Villa NE, et al. Unequal impact of structural health determinants and comorbidity on COVID-19 severity and lethality in older mexican adults: considerations beyond chronological aging. J Gerontol. 2020. doi:10.1093/gerona/glaa163
   Google Scholar
• Atkins JL, Masoli JAH, Delgado J, et al. Preexisting comorbidities predicting COVID-19 and mortality in the UK biobank community cohort. J Gerontol. 2020;75:2224–2230. doi:10.1093/gerona/glaa183
   Google Scholar
• Xu H, Zhong L, Deng J, Peng J, Chen Q. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Ence. 2020;12(1):8.
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620–2629. doi:10.1172/JCI13724432217835
   PubMed Web of Science ®Google Scholar
• Zhang Y, Mo P, Ma Z, et al. Characteristics of peripheral lymphocyte subset alteration in COVID-19 Pneumonia. J Infect Dis. 2020;221(11):1762–1769. doi:10.1093/infdis/jiaa15032227123
   PubMed Web of Science ®Google Scholar
• Wan S, Yi Q, Fan S, et al. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID‐19) infected patients. Br J Haematol. 2020;189(3):428–437. doi:10.1111/bjh.1665932297671
   PubMed Web of Science ®Google Scholar
• Fung S-Y, Yuen K-S, Ye Z-W, Chan C-P, Jin D-Y. A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses. Emerg Microbes Infect. 2020;9(1):558–570. doi:10.1080/22221751.2020.173664432172672
   PubMed Web of Science ®Google Scholar
• Giamarellos-Bourboulis EJ, Netea MG, Rovina N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27(6):992–1000 e1003. doi:10.1016/j.chom.2020.04.00932320677
   PubMed Web of Science ®Google Scholar
• Jamilloux Y, Henry T, Belot A, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev. 2020;19(7):102567. doi:10.1016/j.autrev.2020.10256732376392
   PubMed Web of Science ®Google Scholar
• Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduction Targeted Therapy. 2020;5(1):33.32296069
   PubMed Web of Science ®Google Scholar
• Ge YL, Liu CH, Wang N, et al. Elevated plasma d-dimer in adult community-acquired pneumonia patients is associated with an increased inflammatory reaction and lower survival. Clin Lab. 2019;65:1. doi:10.7754/Clin.Lab.2018.180720
   Web of Science ®Google Scholar
• Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. doi:10.1056/NEJMc200757532268022
   PubMed Web of Science ®Google Scholar
• Leung C. Risk factors for predicting mortality in elderly patients with COVID-19: A review of clinical data in China. Mech Ageing Dev. 2020;188:111255. doi:10.1016/j.mad.2020.11125532353398
   PubMed Web of Science ®Google Scholar